Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 359

1.

The nature of anger in people with multiple sclerosis: a qualitative study.

Laing CM, Cooper CL, Summers F, Lawrie L, O'Flaherty S, Phillips LH.

Psychol Health. 2019 Nov 22:1-14. doi: 10.1080/08870446.2019.1691726. [Epub ahead of print]

PMID:
31757171
2.

Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?

Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, Hogg R, Cooper CL; Canadian Observational Cohort (CANOC) Collaboration.

BMC Infect Dis. 2019 Nov 21;19(1):982. doi: 10.1186/s12879-019-4617-8.

3.

Erythema multiforme major associated with Mycoplasma pneumoniae infection.

Bau JT, Cooper CL.

CMAJ. 2019 Oct 28;191(43):E1195. doi: 10.1503/cmaj.190850. No abstract available.

4.

Correction to: HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study.

Cooper CL, Galanakis C, Donelle J, Kwong JC, Boyd R, Boucher L, Kendall CE.

BMC Infect Dis. 2019 Oct 24;19(1):889. doi: 10.1186/s12879-019-4579-x.

5.

Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network.

Coffin CS, Ramji A, Cooper CL, Miles D, Doucette KE, Wong P, Tam E, Wong DK, Wong A, Ukabam S, Bailey RJ, Tsoi K, Conway B, Barrett L, Michalak TI, Congly SE, Minuk G, Kaita K, Kelly E, Ko HH, Janssen HLA, Uhanova J, Lethebe BC, Haylock-Jacobs S, Ma MM, Osiowy C, Fung SK; Canadian HBV Network.

CMAJ Open. 2019 Oct 22;7(4):E610-E617. doi: 10.9778/cmajo.20190103. Print 2019 Oct-Dec. Erratum in: CMAJ Open. 2019 Dec 3;7(4):E699.

6.

Protective Immunity and New Vaccines for Lyme Disease.

Gomes-Solecki M, Arnaboldi PM, Backenson PB, Benach JL, Cooper CL, Dattwyler RJ, Diuk-Wasser M, Fikrig E, Hovius JW, Laegreid W, Lundberg U, Marconi RT, Marques AR, Molloy P, Narasimhan S, Pal U, Pedra JHF, Plotkin S, Rock DL, Rosa P, Telford SR, Tsao J, Yang XF, Schutzer SE.

Clin Infect Dis. 2019 Oct 17. pii: ciz872. doi: 10.1093/cid/ciz872. [Epub ahead of print]

PMID:
31620776
7.

MRI in the diagnosis of fetal developmental brain abnormalities: the MERIDIAN diagnostic accuracy study.

Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Embleton N, Graham R, Hart AR, Jarvis D, Kilby MD, Lie M, Mason G, Mandefield L, Mooney C, Pennington R, Robson SC, Wailoo A.

Health Technol Assess. 2019 Sep;23(49):1-144. doi: 10.3310/hta23490.

8.

Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.

Thomas SA, Drummond AE, Lincoln NB, Palmer RL, das Nair R, Latimer NR, Hackney GL, Mandefield L, Walters SJ, Hatton RD, Cooper CL, Chater TF, England TJ, Callaghan P, Coates E, Sutherland KE, Eshtan SJ, Topcu G.

Health Technol Assess. 2019 Sep;23(47):1-176. doi: 10.3310/hta23470.

9.

Multilamellar Vaccine Particle Elicits Potent Immune Activation with Protein Antigens and Protects Mice against Ebola Virus Infection.

Fan Y, Stronsky SM, Xu Y, Steffens JT, van Tongeren SA, Erwin A, Cooper CL, Moon JJ.

ACS Nano. 2019 Oct 22;13(10):11087-11096. doi: 10.1021/acsnano.9b03660. Epub 2019 Sep 12.

PMID:
31497947
10.

Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8+ T-Cells in Advanced Liver Disease.

Vranjkovic A, Deonarine F, Kaka S, Angel JB, Cooper CL, Crawley AM.

Front Immunol. 2019 Aug 13;10:1926. doi: 10.3389/fimmu.2019.01926. eCollection 2019.

11.

HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study.

Cooper CL, Galanakis C, Donelle J, Kwong J, Boyd R, Boucher L, Kendall CE.

BMC Infect Dis. 2019 Aug 23;19(1):712. doi: 10.1186/s12879-019-4315-6. Erratum in: BMC Infect Dis. 2019 Oct 24;19(1):889.

12.

An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis.

Smith HW, Hirukawa A, Sanguin-Gendreau V, Nandi I, Dufour CR, Zuo D, Tandoc K, Leibovitch M, Singh S, Rennhack JP, Swiatnicki M, Lavoie C, Papavasiliou V, Temps C, Carragher NO, Unciti-Broceta A, Savage P, Basik M, van Hoef V, Larsson O, Cooper CL, Vargas Calderon AC, Beith J, Millar E, Selinger C, Giguère V, Park M, Harris LN, Varadan V, Andrechek ER, O'Toole SA, Topisirovic I, Muller WJ.

Nat Commun. 2019 Jul 1;10(1):2901. doi: 10.1038/s41467-019-10681-4.

13.

The impact of public transport on the health of work commuters: a systematic review.

Norgate SH, Cooper-Ryan AM, Lavin S, Stonier C, Cooper CL.

Health Psychol Rev. 2019 Jun 12:1-20. doi: 10.1080/17437199.2019.1618723. [Epub ahead of print]

PMID:
31117887
14.

Chronic Hepatitis C Virus Infection Impairs M1 Macrophage Differentiation and Contributes to CD8+ T-Cell Dysfunction.

Ahmed F, Ibrahim A, Cooper CL, Kumar A, Crawley AM.

Cells. 2019 Apr 25;8(4). pii: E374. doi: 10.3390/cells8040374.

15.

Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters.

Doyle MA, Galanakis C, Mulvihill E, Crawley A, Cooper CL.

Cells. 2019 Mar 15;8(3). pii: E252. doi: 10.3390/cells8030252.

16.

Sterol A-ring plasticity in hedgehog protein cholesterolysis supports a primitive substrate selectivity mechanism.

Ciulla DA, Wagner AG, Liu X, Cooper CL, Jorgensen MT, Wang C, Goyal P, Banavali NK, Pezzullo JL, Giner JL, Callahan BP.

Chem Commun (Camb). 2019 Feb 5;55(12):1829-1832. doi: 10.1039/c8cc09729a.

17.

Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses.

Bazzill JD, Stronsky SM, Kalinyak LC, Ochyl LJ, Steffens JT, van Tongeren SA, Cooper CL, Moon JJ.

Nanomedicine. 2019 Jun;18:414-425. doi: 10.1016/j.nano.2018.11.005. Epub 2018 Nov 22.

PMID:
30471480
18.

In situ Study Unravels Bio-Nanomechanical Behavior in a Magnetic Bacterial Nano-cellulose (MBNC) Hydrogel for Neuro-Endovascular Reconstruction.

Pavón JJ, Allain JP, Verma D, Echeverry-Rendón M, Cooper CL, Reece LM, Shetty AR, Tomar V.

Macromol Biosci. 2019 Feb;19(2):e1800225. doi: 10.1002/mabi.201800225. Epub 2018 Nov 19.

PMID:
30451373
19.

Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieu.

Driedger M, Galanakis C, Doyle MA, Cooper CL.

Eur J Gastroenterol Hepatol. 2019 Feb;31(2):260-266. doi: 10.1097/MEG.0000000000001292.

PMID:
30379706
20.

An Evaluation of Rapidly Progressive Dementia Culminating in a Diagnosis of Creutzfeldt-Jakob Disease.

Parmar P, Cooper CL, Kobewka D.

Case Rep Infect Dis. 2018 Sep 23;2018:2374179. doi: 10.1155/2018/2374179. eCollection 2018.

21.

Examining the contribution of smoking and HPV towards the etiology of oral cavity squamous cell carcinoma using high-throughput sequencing: A prospective observational study.

Zammit AP, Sinha R, Cooper CL, Perry CFL, Frazer IH, Tuong ZK.

PLoS One. 2018 Oct 11;13(10):e0205406. doi: 10.1371/journal.pone.0205406. eCollection 2018.

22.

A study of target effect sizes in randomised controlled trials published in the Health Technology Assessment journal.

Rothwell JC, Julious SA, Cooper CL.

Trials. 2018 Oct 10;19(1):544. doi: 10.1186/s13063-018-2886-y.

23.

No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients.

Sarrazin C, Cooper CL, Manns MP, Reddy KR, Kowdley KV, Roberts SK, Dvory-Sobol H, Svarovskia E, Martin R, Camus G, Doehle BP, Stamm LM, Hyland RH, Brainard DM, Mo H, Gordon SC, Bourliere M, Zeuzem S, Flamm SL.

J Hepatol. 2018 Dec;69(6):1221-1230. doi: 10.1016/j.jhep.2018.07.023. Epub 2018 Aug 9.

PMID:
30098373
24.

Now Is the Time to Quickly Eliminate Barriers Along the Hepatitis C Cascade of Care.

Cooper CL.

J Infect Dis. 2018 May 25;217(12):1858-1860. doi: 10.1093/infdis/jiy117. No abstract available.

PMID:
29534217
25.

The TiM system: developing a novel telehealth service to improve access to specialist care in motor neurone disease using user-centered design.

Hobson EV, Baird WO, Partridge R, Cooper CL, Mawson S, Quinn A, Shaw PJ, Walsh T, Wolstenholme D, Mcdermott CJ.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):351-361. doi: 10.1080/21678421.2018.1440408. Epub 2018 Feb 16.

26.

Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: A review of publicly funded trials.

Cooper CL, Whitehead A, Pottrill E, Julious SA, Walters SJ.

Clin Trials. 2018 Apr;15(2):189-196. doi: 10.1177/1740774517752113. Epub 2018 Jan 23.

27.

Hepatitis C virus core protein reduces CD8+ T-cell proliferation, perforin production and degranulation but increases STAT5 activation.

Khan ST, Karges W, Cooper CL, Crawley AM.

Immunology. 2018 May;154(1):156-165. doi: 10.1111/imm.12882. Epub 2018 Jan 25.

28.

Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients.

Cooper CL, Hatashita H, Corsi DJ, Parmar P, Corrin R, Garber G.

Ann Hepatol. 2017 November-December,;16(6):874-880. doi: 10.5604/01.3001.0010.5277.

29.

Pulmonary schistosomiasis mimicking IgG4-related lung disease.

Baird T, Cooper CL, Wong R, Runnegar N, Keir G.

Respirol Case Rep. 2017 Oct 16;6(1):e00276. doi: 10.1002/rcr2.276. eCollection 2018 Jan.

30.

Quantitative Analysis of Repertoire-Scale Immunoglobulin Properties in Vaccine-Induced B-Cell Responses.

Khavrutskii IV, Chaudhury S, Stronsky SM, Lee DW, Benko JG, Wallqvist A, Bavari S, Cooper CL.

Front Immunol. 2017 Aug 14;8:910. doi: 10.3389/fimmu.2017.00910. eCollection 2017.

31.

Hepatitis C Virus Infection Outcomes Among Immigrants to Canada: A Retrospective Cohort Analysis.

Cooper CL, Thavorn K, Damian E, Corsi DJ.

Ann Hepatol. 2017 Sep-Oct;16(5):720-726. doi: 10.5604/01.3001.0010.2714.

32.

Punch 'scoring': a technique that facilitates melanoma diagnosis of clinically suspicious pigmented lesions.

Grogan J, Cooper CL, Dodds TJ, Guitera P, Menzies SW, Scolyer RA.

Histopathology. 2018 Jan;72(2):294-304. doi: 10.1111/his.13342. Epub 2017 Oct 17.

PMID:
28796900
33.

T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection.

Cooper CL, Martins KA, Stronsky SM, Langan DP, Steffens J, Van Tongeren S, Bavari S.

Emerg Microbes Infect. 2017 Jun 7;6(6):e46. doi: 10.1038/emi.2017.31.

34.

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.

Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S; POLARIS-1 and POLARIS-4 Investigators.

N Engl J Med. 2017 Jun 1;376(22):2134-2146. doi: 10.1056/NEJMoa1613512.

35.

Liver enzyme normalization predicts success of Hepatitis C oral direct-acting antiviral treatment.

Khan ST, McGuinty M, Corsi DJ, Cooper CL.

Clin Invest Med. 2017 Apr 26;40(2):E73-E80. doi: 10.25011/cim.v40i2.28198.

PMID:
28447580
36.

Change in diagnostic confidence brought about by using in utero MRI for fetal structural brain pathology: analysis of the MERIDIAN cohort.

Griffiths PD, Bradburn M, Campbell MJ, Connolly DJA, Cooper CL, Jarvis D, Kilby MD, Mason G, Mooney C, Robson SC, Wailoo A; MERIDIAN Collaborative Group.

Clin Radiol. 2017 Jun;72(6):451-457. doi: 10.1016/j.crad.2017.01.009. Epub 2017 Feb 24.

37.

Effect of Different Types of Physical Activity on Activities of Daily Living in Older Adults: Systematic Review and Meta-Analysis.

Roberts CE, Phillips LH, Cooper CL, Gray S, Allan JL.

J Aging Phys Act. 2017 Oct 1;25(4):653-670. doi: 10.1123/japa.2016-0201. Epub 2017 Sep 23. Review.

PMID:
28181837
38.

BRILIA: Integrated Tool for High-Throughput Annotation and Lineage Tree Assembly of B-Cell Repertoires.

Lee DW, Khavrutskii IV, Wallqvist A, Bavari S, Cooper CL, Chaudhury S.

Front Immunol. 2017 Jan 17;7:681. doi: 10.3389/fimmu.2016.00681. eCollection 2016.

39.

Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.

Marshall AD, Saeed S, Barrett L, Cooper CL, Treloar C, Bruneau J, Feld JJ, Gallagher L, Klein MB, Krajden M, Shoukry NH, Taylor LE, Grebely J; Canadian Network on Hepatitis C (CanHepC).

CMAJ Open. 2016 Oct 14;4(4):E605-E614. doi: 10.9778/cmajo.20160008. eCollection 2016 Oct-Dec.

40.

PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term - a cluster randomised controlled trial and economic evaluation.

Julious SA, Horspool MJ, Davis S, Bradburn M, Norman P, Shephard N, Cooper CL, Smithson WH, Boote J, Elphick H, Loban A, Franklin M, Kua WS, May R, Campbell J, Williams R, Rex S, Bortolami O.

Health Technol Assess. 2016 Dec;20(93):1-154. doi: 10.3310/hta20930.

41.

Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study.

Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Graham R, Jarvis D, Kilby MD, Mason G, Mooney C, Robson SC, Wailoo A; MERIDIAN collaborative group.

Lancet. 2017 Feb 4;389(10068):538-546. doi: 10.1016/S0140-6736(16)31723-8. Epub 2016 Dec 15.

42.

The impact of ADHD on the health and well-being of ADHD children and their siblings.

Peasgood T, Bhardwaj A, Biggs K, Brazier JE, Coghill D, Cooper CL, Daley D, De Silva C, Harpin V, Hodgkins P, Nadkarni A, Setyawan J, Sonuga-Barke EJ.

Eur Child Adolesc Psychiatry. 2016 Nov;25(11):1217-1231. Epub 2016 Apr 1.

43.

Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.

Key J, Dhawan D, Cooper CL, Knapp DW, Kim K, Kwon IC, Choi K, Park K, Decuzzi P, Leary JF.

Int J Nanomedicine. 2016 Aug 29;11:4141-55. doi: 10.2147/IJN.S109494. eCollection 2016.

44.

Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose.

Chahal JS, Khan OF, Cooper CL, McPartlan JS, Tsosie JK, Tilley LD, Sidik SM, Lourido S, Langer R, Bavari S, Ploegh HL, Anderson DG.

Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):E4133-42. doi: 10.1073/pnas.1600299113. Epub 2016 Jul 5. Erratum in: Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):E5250.

45.

Synthesis and in vitro safety assessment of magnetic bacterial cellulose with porcine aortic smooth muscle cells.

Pastrana HF, Cooper CL, Alucozai M, Reece LM, Avila AG, Allain JP.

J Biomed Mater Res A. 2016 Nov;104(11):2801-9. doi: 10.1002/jbm.a.35824. Epub 2016 Jul 17.

PMID:
27376695
46.

DiPALS: Diaphragm Pacing in patients with Amyotrophic Lateral Sclerosis - a randomised controlled trial.

McDermott CJ, Bradburn MJ, Maguire C, Cooper CL, Baird WO, Baxter SK, Cohen J, Cantrill H, Dixon S, Ackroyd R, Baudouin S, Bentley A, Berrisford R, Bianchi S, Bourke SC, Darlison R, Ealing J, Elliott M, Fitzgerald P, Galloway S, Hamdalla H, Hanemann CO, Hughes P, Imam I, Karat D, Leek R, Maynard N, Orrell RW, Sarela A, Stradling J, Talbot K, Taylor L, Turner M, Simonds AK, Williams T, Wedzicha W, Young C, Shaw PJ.

Health Technol Assess. 2016 Jun;20(45):1-186. doi: 10.3310/hta20450.

47.

Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.

Burke Schinkel SC, Carrasco-Medina L, Cooper CL, Crawley AM.

PLoS One. 2016 Jun 17;11(6):e0157055. doi: 10.1371/journal.pone.0157055. eCollection 2016.

48.

Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis.

Costiniuk CT, Brunet L, Rollet-Kurhajec KC, Cooper CL, Walmsley SL, Gill MJ, Martel-Laferriere V, Klein MB.

Open Forum Infect Dis. 2016 Mar 7;3(2):ofw050. doi: 10.1093/ofid/ofw050. eCollection 2016 Mar.

49.

siRNA Screen Identifies Trafficking Host Factors that Modulate Alphavirus Infection.

Radoshitzky SR, Pegoraro G, Chī XO, D Ng L, Chiang CY, Jozwick L, Clester JC, Cooper CL, Courier D, Langan DP, Underwood K, Kuehl KA, Sun MG, Caì Y, Yú SQ, Burk R, Zamani R, Kota K, Kuhn JH, Bavari S.

PLoS Pathog. 2016 Mar 31;12(3):e1005466. doi: 10.1371/journal.ppat.1005466. eCollection 2016 Mar.

50.

Using technology to improve access to specialist care in amyotrophic lateral sclerosis: A systematic review.

Hobson EV, Baird WO, Cooper CL, Mawson S, Shaw PJ, Mcdermott CJ.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):313-24. doi: 10.3109/21678421.2016.1165255. Epub 2016 Mar 30. Review.

Supplemental Content

Loading ...
Support Center